文献速递痛风与晶体性关节病

FFAR2与SOCS3基因表达上调与痛风相关

Upregulated expression of FFAR2 and SOC3 genes is associated with gout.
PubMed 文献 · Rheumatology (Oxford) · 2023-01-01

研究纳入120人,检测无症状高尿酸血症、间歇期痛风及痛风发作期FFAR2与SOCS3基因表达,发现FFAR2在痛风发作期和间歇期均显著上调,SOCS3在发作期上调且与发作持续时间负相关。

要点

  • 痛风发作期FFAR2表达较血尿酸正常、无症状高尿酸血症及高尿酸血症伴MSU沉积显著上调(FC=2.9 vs 1.1,P<0.0001)。
  • 间歇期痛风FFAR2亦显著上调(FC=1.8 vs 1.1,P<0.001)。
  • 痛风发作期SOCS3显著上调(FC=3.4),且SOCS3表达与发作持续时间呈负相关(r=-0.49,P<0.05)。

核心结论

  • FFAR2表达上调与痛风相关,可能触发痛风发作;SOCS3可能参与痛风发作的缓解。

研究设计与样本

  • 研究共纳入120名参与者,包括34例血清尿酸<360 μmol/l者、69例无症状高尿酸血症±MSU晶体沉积者及17例痛风发作者。
  • 17例痛风发作者中16例在6-12周后进行了第二次随访。
  • 基因表达水平采用RT-qPCR评估,结果以经内参基因归一化后的倍数变化(FC)表示。

主要发现

  • 痛风发作期FFAR2表达(FC=2.9)显著高于血尿酸正常、无症状高尿酸血症及高尿酸血症伴MSU晶体沉积者(FC=1.1,每项比较P<0.0001)。
  • 间歇期痛风FFAR2表达(FC=1.8)显著高于血尿酸正常、无症状高尿酸血症及高尿酸血症伴MSU沉积者(FC=1.1,每项比较P<0.001)。
  • 痛风发作期SOCS3表达(FC=3.4)显著高于血尿酸正常、无症状高尿酸血症及高尿酸血症伴MSU晶体沉积者(FC分别为1.1、1.1、1.2,每项比较P<0.0001)。
  • 间歇期痛风SOCS3表达(FC=2.1)高于血尿酸正常者(FC=1.1,P=0.02)及无症状高尿酸血症者(FC=1.2,P=0.006)。
  • 痛风发作期FFAR2表达较间歇期痛风上调,SOCS3表达与发作持续时间呈负相关(r=-0.49,P<0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the expression of Free fatty acid receptor 2 (FFAR2) and Suppressor of cytokine signalling 3 (SOCS3) genes in asymptomatic hyperuricaemia (AH), AH with MSU crystal deposition, inter-critical gout and gout flare. METHODS: Study participants (n = 120) comprised 34 people with serum urate (SU) <360 μmol/l, 69 with AH ± MSU crystal deposition and 17 with a gout flare. Sixteen of the 17 patients with a gout flare attended a second visit 6-12 weeks later. Gene expression levels were assessed using RT-qPCR and results computed as fold changes (FC) after normalization to the reference gene. RESULTS: FFAR2 was significantly upregulated during gout flares (FC = 2.9) compared with normal SU, AH, and AH + MSU crystal deposition (FC = 1.1, P < 0.0001 for each comparison). FFAR2 was also significantly upregulated during inter-critical gout (FC = 1.8) compared with normal SU, AH and AH + MSU (FC = 1.1, P < 0.001 for each comparison). SOCS3 was significantly upregulated during gout flares (FC = 3.4) compared with normal SU, AH, and AH + MSU crystal deposition (FC = 1.1, 1.1 and 1.2, respectively, P < 0.0001 for each comparison). SOCS3 was also upregulated during inter-critical gout (FC = 2.1) compared with normal SU (P = 0.02) and AH (P = 0.006) (FC = 1.1 and 1.2, respectively). FFAR2 expression was upregulated during gout flare compared with inter-critical gout and SOCS3 expression showed negative correlation with flare duration (r = -0.49, P < 0.05). CONCLUSION: FFAR2 upregulation is associated with gout and may trigger gout flares. SOCS3 may have a role in amelioration of gout flares.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Orji OC, López-Domínguez MB, Sandoval-Plata G, et al. Upregulated expression of FFAR2 and SOC3 genes is associated with gout. Rheumatology (Oxford). 2023. PMID: 35731142. doi:10.1093/rheumatology/keac360

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。